Delivery Order SPE2DB25D3022-SPE2DB25FWCMF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vitamin D2 1.25mg (50,000 unit) tablets in quantities of 100 per unit, with a ceiling value of $26,081.28. This firm fixed-price delivery order was awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued...
- This federal contract award, valued at $8,401.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vitamin D2 1.25mg (50,000 unit) tablets, to be completed by December 30, 2024. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,632.86, is for the delivery of vitamin D2 tablets (4568164354 ! VIT D2 1.25MG 100S) and has a performance period through June 4, 2025. The contract is a firm-fixed-price, non-set-aside delivery order. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award, valued at $6,302.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of vitamin D2 1.25mg (50,000 unit) tablets, with a completion date of June 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,546.59, is for the delivery of Vitamin D2 1.25MG (50,000 unit) in 100-count bottles. The contract is a Delivery Order and has a Firm Fixed Price pricing type, with a completion date of December 5, 2024. This contract does not have a set-aside designation, indicating open competition....
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,068.45, is for the delivery of 4567825222 - VITAMIN D2 1.25MG (50,000 UNIT) 100S. It is a firm fixed-price delivery order with an ultimate completion date of April 8, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,822.59 firm fixed price delivery order is for the supply of 4,566,554,652 units of Vitamin D2 1.25MG (50,000 unit) in 100-count bottles. The contract has a performance period through November 27, 2024 and was awarded on November 26, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,316.88, is for the delivery of Vitamin D2 1.25mg (50,000 unit) 100s medication. The contract is a firm fixed-price delivery order with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for Vitamin D3 400 IU/mL pharmaceutical supply with a ceiling value of $1,468.80. This firm fixed-price delivery order, which falls under a non-competitive set-aside, is scheduled for completion by October 2, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,264.63, is for the procurement of Vitamin D2 1.25mg (50,000 unit) 100s. The order has an ultimate completion date of April 10, 2025. This contract is not associated with a set-aside program and is part of AmerisourceBergen's extensive Indefinite Delivery Contract (IDC) with the...
- SPE2DB25D3022Indefinite Delivery Contract
- SPE2DB25D3022-SPE2DB25FWCMFDelivery Order
The Defense Logistics Agency awarded a $6,137.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vitamin D2 1.25mg (50,000 unit) tablets in a quantity of 100 units. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of September 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform work at its Corporate Office location. This delivery order represents a small-value transaction within the company's broader federal pharmaceutical supply portfolio. This award is issued as a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a diverse range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The arrangement reflects AmerisourceBergen Drug Corp's established capability as a critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 9/8/25 |